Search filters

List of works by P Noel Barrett

A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals ⬇️

scientific article published on January 19, 2012

A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato

scientific article

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations ⬇️

scientific article (publication date: 16 August 2010)

A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies ⬇️

scientific article published on November 16, 2011

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

scientific article

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination ⬇️

scientific article published on June 29, 2012

A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate ⬇️

scientific article published on May 10, 2012

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

scientific article

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

scientific article

A new approach to a Lyme disease vaccine

scientific article published on 01 February 2011

A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory

scientific article published on July 28, 2012

A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies

scientific article published in September 2013

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

scientific article published on June 2011

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

scientific article

Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1)

scientific article published on 01 July 2011

An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial

scientific article

An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system

scientific article

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.

scientific article published on June 2012

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

scientific article

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

scientific article

Chikungunya virus and the safety of plasma products ⬇️

scientific article published on February 17, 2012

Clinical development of a Vero cell culture-derived seasonal influenza vaccine ⬇️

scientific article published on December 13, 2011

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine

scientific article published on 7 May 2010

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

scientific article published on 28 April 2010

Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model.

scientific article

Developing cell culture-derived pandemic vaccines.

scientific article

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial ⬇️

scientific article published on February 15, 2011

Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model

scientific article

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

scientific article

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model

scientific article (publication date: 2011)

History of TBE vaccines

scientific article published in April 2003

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice

scientific article

Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.

scientific article

Lyme disease vaccination: safety first - authors' reply

scientific article published on 01 January 2014

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

scientific article

Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines

scientific article published on 9 December 2015

Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients

scientific article published on 25 August 2014

Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.

scientific article

Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects

scientific article published on 20 December 2016

Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.

scientific article

Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever ⬇️

scientific article published on September 9, 2011

Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines.

scientific article

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

scientific article

Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

scientific article

Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza ⬇️

scientific article published on October 7, 2011

Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.

scientific article published on 16 August 2011

Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes

scientific article published on 14 December 2011

Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR.

scientific article

Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects

scientific article published on 31 October 2016

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity ⬇️

scientific article published on December 12, 2003

Re: Tick-borne encephalitis (TBE) trends in epidemiology and current and future management

scientific article published on 21 February 2011

Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives

scientific article published on 01 July 2006

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

scientific article published on 10 May 2013

Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients

scientific article

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

scientific article

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

scientific article published on 12 October 2011

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine

scientific article

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study

scientific article

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study

article

Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination

scientific article published on 16 December 2009

The need for a new vaccine against lyme borreliosis ⬇️

scientific article published on 01 February 2013

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity ⬇️

scientific article (publication date: 24 January 2011)

Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development ⬇️

scientific article published on April 1, 2013

Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.

scientific article

Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

scientific article published on 20 July 2017

Paulina is supported by:

About Paulina

Help